Skip to content

Funding
Launch
Partnership
Acquisition
Policy
Exit & IPO

MSD

MSD Secures Reimbursement Approval for Von Hippel-Lindau Treatment in Italy

June 8, 2026 by Marco Bianchi

MSD’s belzutifan treatment for Von Hippel-Lindau syndrome receives reimbursement approval in Italy

Categories Launch Tags Healthtech, Italy, MSD Leave a comment

Browse by Country

Latest

Znext, Zanichelli-Backed Venture Builder, Expands Into Spain With New M&A LeadershipJul 28, 2026

Dwelly Secures $170 Million to Expand AI-Powered Letting Agency Rollup Across UKJul 28, 2026

German VC Visionaries Club Streamlines Team with GP-Led Model ShiftJul 28, 2026

Dutch Medtech Startup Xeltis Secures €20.5 Million to Advance Vascular Implant TechnologyJul 28, 2026

Swedish Fintech Billhop Exits to US Payment Platform Ramp Amid Revenue GrowthJul 28, 2026

EU Markets

European Markets Flash Both Green and Red for Startups: What This Week's Financial Moves Mean for YouJul 24, 2026

Defence Funds, AI Warnings, and a €30B Bank Battle: What Europe's Financial Markets Mean for Your Startup This WeekJul 17, 2026

Digital Euros, Defense Billions, and AI Pivots: What Europe's Financial Markets Mean for Your Startup This WeekJul 10, 2026

Techstars Startup Weekend to Put the Isle of Man on the Global Startup MapJul 5, 2026

EU Startups News

• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.